.svg)
Albendazole 400 Mg
Price range: $24.00 through $60.00
Albendazole 400 Mg is a broad-spectrum antiparasitic medication commonly used in human medicine to treat infections caused by intestinal worms and other helminths. It belongs to the benzimidazole class of drugs and works by inhibiting the parasite’s ability to absorb glucose, leading to energy depletion and eventual parasite death. Albendazole is widely prescribed for conditions such as roundworm, hookworm, pinworm infections, neurocysticercosis, and hydatid disease caused by tapeworm larvae.
Beyond its established role in treating parasitic infections, Albendazole has also gained attention in scientific research exploring drug repurposing in oncology. Preclinical studies suggest that Albendazole may interfere with microtubule formation in rapidly dividing cells, which could potentially inhibit tumor growth and trigger apoptosis in certain cancer cell lines. However, these findings remain investigational, and Albendazole is not currently approved as a standard cancer treatment.
For medical safety, Albendazole should always be used under the supervision of a qualified healthcare professional, especially in long-term therapies where monitoring of liver function may be recommended.
Description
Albendazole 400 Mg | Broad-Spectrum Antiparasitic Benzimidazole Compound
Albendazole 400 Mg – Benzimidazole Compound Studied in Parasitic and Experimental Cancer Research
Albendazole 400 Mg contains albendazole, a broad-spectrum benzimidazole compound widely used for treating parasitic worm infections. Albendazole works by disrupting microtubule formation inside parasite cells, preventing them from absorbing nutrients and maintaining cellular structure.
Microtubules are essential cellular structures responsible for cell division, intracellular transport, and structural stability. Because cancer cells rely heavily on rapid division, scientists have investigated whether microtubule-targeting compounds such as albendazole could influence tumor growth pathways in laboratory studies.
Experimental research has demonstrated that albendazole may interfere with tumor cell proliferation and induce programmed cell death in certain cancer cell models.
Researchers studying benzimidazole compounds sometimes compare albendazole with related compounds such as Fenbendazole Tablets 500 Mg when examining microtubule-targeting mechanisms.
Higher-strength benzimidazole formulations like Fenbendazole Tablets 1000 Mg may also be referenced in research evaluating antiparasitic compounds and their biological effects on cellular metabolism.
What is Albendazole 400 Mg?
Albendazole 400 Mg is an antiparasitic medication belonging to the benzimidazole class of drugs, which are widely used to treat infections caused by parasitic worms. Albendazole works by binding to β-tubulin proteins in parasite cells, preventing the formation of microtubules required for cell division and nutrient absorption.
This disruption leads to impaired glucose uptake and depletion of the parasite’s energy stores, eventually causing parasite death.
Albendazole is commonly used in medical treatment for parasitic infections such as:
Roundworms
Tapeworm infections
Hydatid disease
Neurocysticercosis
Hookworm infections
Because microtubules also play a critical role in cancer cell division, researchers have explored whether albendazole may influence tumor cell survival in laboratory studies.
Why Albendazole Has Attracted Interest in Cancer Research
Cancer cells divide rapidly and rely on structural proteins such as microtubules to complete mitosis. Many chemotherapy drugs target microtubules to prevent tumor cells from multiplying.
Laboratory research has shown that albendazole can disrupt microtubule assembly in cancer cells, leading to cell cycle arrest and apoptosis in certain experimental models.
Studies have also shown that albendazole may inhibit the growth of pancreatic cancer cells and reduce tumor proliferation in experimental models.
Additional experimental observations suggest that albendazole may:
Disrupt microtubule polymerization
Reduce tumor cell proliferation
Influence apoptosis-related pathways
Affect cancer cell migration and metabolic pathways
These findings continue to be explored in preclinical research investigating the potential repurposing of antiparasitic compounds in oncology.
Key Features of Albendazole 400 Mg
Broad-Spectrum Antiparasitic Compound
Albendazole is widely used to treat multiple parasitic worm infections.
Benzimidazole Microtubule Inhibitor
The compound works by interfering with β-tubulin proteins responsible for microtubule formation.
Studied in Experimental Oncology Research
Laboratory studies have investigated albendazole’s effect on cancer cell proliferation and apoptosis.
Well-Known Anthelmintic Agent
Albendazole has been used globally in parasite control programs and medical treatments for worm infections.
Potential Research Applications
Researchers have investigated albendazole compounds in several scientific areas, including:
Antiparasitic drug development
Microtubule-targeting drug research
Cancer cell metabolism studies
Drug repurposing in oncology
Experimental tumor growth models
Most of these studies remain limited to preclinical or laboratory research settings.
Scientific Research on Albendazole and Cancer Cells
Several scientific studies have explored the biological effects of albendazole on cancer cells. Laboratory research has demonstrated that albendazole may cause mitotic arrest and apoptosis in human gastric cancer cells by disrupting microtubule formation.
Additional research has also shown that albendazole reduced the proliferation and migration of pancreatic cancer cells while increasing apoptosis in experimental models.
For more evidence-based information about cancer biology and emerging therapeutic research, the following authoritative resources provide reliable educational material:National Cancer Institute – Understanding Cancer Biology
Who May Explore Albendazole 400 Mg?
Albendazole compounds may be explored by researchers and healthcare professionals studying:
Antiparasitic drug mechanisms
Benzimidazole microtubule inhibitors
Cancer cell metabolism research
Drug repurposing strategies in oncology
Any pharmaceutical compound should only be used under proper medical supervision or research conditions.
Safety and Medical Disclaimer
Albendazole is approved in many countries for the treatment of parasitic infections. However, its use for treating cancer remains experimental and not approved by major regulatory agencies.
FAQs
Albendazole 400 Mg is commonly used to treat infections caused by parasitic worms. It belongs to the benzimidazole class of medications and works by disrupting the parasite’s ability to absorb nutrients and maintain cellular structure. This process eventually leads to parasite death. Albendazole is widely used in global parasite control programs and in clinical treatment of infections such as neurocysticercosis and hydatid disease. In addition to its antiparasitic effects, researchers have investigated albendazole in laboratory studies to explore whether it may influence cancer cell growth through microtubule disruption mechanisms.
Albendazole works by binding to β-tubulin proteins inside parasite cells. Tubulin proteins assemble into microtubules, which are necessary for cell division and nutrient transport. When albendazole interferes with tubulin polymerization, parasite cells lose their ability to absorb glucose and produce energy. This disruption causes energy depletion and eventually leads to parasite death. The same microtubule-targeting mechanism is the reason researchers have investigated albendazole’s effects on rapidly dividing cancer cells in laboratory experiments.
Several studies have shown that Albendazole can inhibit cancer cell proliferation and induce apoptosis in certain tumor cell lines, including colon and pancreatic cancer cells. However, these findings mainly come from laboratory experiments and animal studies. More clinical trials involving human patients are needed before Albendazole could be recommended for oncology treatment.
Albendazole has attracted scientific interest because it interferes with microtubules, which are essential structures required for cell division. Many anticancer drugs work by targeting microtubules to stop tumor cells from multiplying. Laboratory studies have demonstrated that albendazole can disrupt microtubule formation and induce apoptosis in several cancer cell models. These findings have encouraged researchers to investigate whether albendazole could potentially be repurposed for oncology applications in experimental studies.
Albendazole is approved for treating parasitic infections in humans. However, it is not approved as a cancer treatment by regulatory agencies such as the FDA. While laboratory studies have shown interesting biological effects on tumor cells, additional clinical trials are required before albendazole could be considered for oncology use.
Albendazole is commonly used to treat infections caused by several types of parasitic worms, including roundworms, hookworms, tapeworms, and certain tissue parasites. It is frequently used to treat conditions such as hydatid disease and neurocysticercosis. Its broad spectrum of activity has made it one of the most widely used antiparasitic medications in many countries.
RELATED PRODUCTS
Artesunate 120 mg Injection
Fenbendazole 222 Mg Tablets
Fenbendazole Tablets 500 Mg
Iverheal 6 Mg – Ivermectin
Ivrea – Ivermectin Cream 1%
Oseltamivir Capsule 30 Mg – Tamiflu
Reviews
There are no reviews yet.